http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104918937-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4353 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04 |
| filingDate | 2013-12-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2016-09-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2016-09-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-104918937-B |
| titleOfInvention | Sibutramine Hydrochloride for Buddhist nun and the crystal formation of solvate thereof, its preparation method, containing their medical composition and its use |
| abstract | The present invention relates to Sibutramine Hydrochloride and replace Buddhist nun and the crystal formation of solvate thereof and its preparation method, and contain the pharmaceutical composition of these crystal formations and the purposes in preparing related drugs thereof.Compared with prior art, Sibutramine Hydrochloride of the present invention has good crystalline state for the crystal formation of Buddhist nun and solvate thereof, stability of crystal form is good, being difficult to moisture absorption, in water, dissolubility improves, and active component content is higher, solvent toxicity is lower, therefore it is more beneficial for meeting the strict demand of pharmaceutical preparation, and these crystal formations can be prepared under room temperature or low temperature, is more beneficial for the industrialized production of product. |
| priorityDate | 2013-12-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 75.